RxDoctor Payments Data

Mary Flowers

Hematology & Oncology · Seattle, WANPI 1386729184

Payments from drug & device makers

$357,435in general payments, 2019–2025

Across 143 payments — averaging $2499.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$261K
  • Pharmacyclics LLC, An Abbvie Company$80K
  • Mallinckrodt Hospital Products Inc.$10K
  • Novartis$6K
  • Astellas Pharma US Inc$190
  • Merck$20
$339in research payments, 2019–2025

Across 2 payments — averaging $169.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$219
  • Pharmacyclics LLC, An Abbvie Company$120

What the payments were for

  • Speaking & faculty fees$10,01098%
  • Education$2102%

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$357,435 in reported general payments places this provider in the 75th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →